Clinical practice guideline: Colorectal carcinoma - The management of polyps, (neo)adjuvant therapy, and the treatment of metastases;Klinische leitlinie: Kolorektales karzinom - Polypenmanagement, (neo)adjuvante therapie, therapie im metastasierten stadium

Deutsches Arzteblatt

Volumn 106, Issue 51-52, 2009, Pages 843-848

  Schmiegel, Wolff ^a,b   Pox, Christian ^a   Arnold, Dirk ^e   Porschen, Rainer ^c   Rödel, Claus ^d   Reinacher Schick, Anke ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c KLINIKUM BREMEN OST   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Adjuvant therapy; Cancer treatment; Colorectal carcinoma; Palliative treatment; Polyps

Indexed keywords

FLUOROPYRIMIDINE; FLUOROURACIL; MOLECULAR MARKER; OXALIPLATIN;

ADJUVANT THERAPY; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COLON POLYP; COLONOSCOPY; COLORECTAL CARCINOMA; CONSENSUS; EVIDENCE BASED MEDICINE; GERMANY; HUMAN; METASTASIS; POLYPECTOMY; PRACTICE GUIDELINE; COLORECTAL TUMOR; ONCOLOGY; STANDARD;

COLONIC POLYPS; COLORECTAL NEOPLASMS; GERMANY; HUMANS; MEDICAL ONCOLOGY; NEOADJUVANT THERAPY;

EID: 77949393787     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2009.0843     Document Type: Article

References (25)

1. Robert Koch-Institut. Krebs in Deutschland 2008.www.rki.de
2. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 627-37.
3. Schmiegel W, Reinacher-Schick A, Arnold D, et al.: S3-Leitlinie "Kolorektales Karzinom" - Aktualisierung 2008. Z Gastroenterol 2008; 46: 799-840.
4. Schönhofer B, Kuhlen R, Neumann P, et al.: Clinical practice guideline: non-invasive mechanical ventilation as treatment of acute respiratory failure [Klinische Leitlinie. Nicht invasive Beatmung bei respiratorischer Insuffizienz]. Dtsch Arztebl Int 2008; 105(24): 424-33.
5. Winawer SJ, Zauber AG, Ho MN, et al.: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977-81.
6. Martinez ME, Baron JA, Lieberman DA, et al.: A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009; 136: 832-41.
7. Brenner H, Hoffmeister M, Stegmaier C, et al.: Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies. Gut 2007; 56: 1585-9.
8. Lieberman DA, Weiss DG, Harford WV, et al.: Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007; 133: 1077-85.
9. Higaki S, Hashimoto S, Harada K, et al.: Long-term follow-up of large flat colorectal tumors resected endoscopically. Endoscopy 2003; 35: 845-9.
10. Jass JR: Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50: 113-30.
11. Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJ: Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest 2006; 129: 734-7.
12. Yousfi M, Gostout CJ, Baron TH, et al.: Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol 2004; 99: 1785-9.
13. Deinlein P, Reulbach U, Stolte M, Vieth M: Risikofaktoren der lymphogenen Metastasierung von kolorektalen pT1-Karzinomen. Pathologe 2003; 24: 387-93.
14. O'Connell JB, Maggard MA, Ko CY: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004; 96: 1420ff.
15. Moertel CG, Fleming TR, Macdonald JS, et al.: Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995; 122: 321-6.
16. André T, Boni C, Navarro M, et al.: Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27: 3109-16.
17. Twelves C, et al.: Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005; 352: 2696-704.
18. Quasar Collaborative Group Gray R, Barnwell J, Mc Conkey C, et al.: Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007; 370: 2020-9.
19. Sargent DJ, Goldberg RM, Jacobson SO, et al.: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001; 345: 1091-7.
20. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus post-operative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-40.
21. Mitry E, Fields AL, Bleiberg H, et al.: Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 2008; 26: 4906-11.
22. Nordlinger B, Sorbye H, Glimelinus B, et al.: Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40 983): a randomised controlled trial. Lancet 2008; 371: 1007-16.
23. Tournigand C, Cervantes A, Figer A, et al.: OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer - a GERCOR study. J Clin Oncol 2006; 24: 394-400.
24. Koopman M, Antonini NF, Douma J, et al.: Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet 2007; 370: 135-42.
25. Seymour MT, Maughan TS, Ledermann JA, et al.: Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial. Lancet 2007; 370: 143-52.